ArticlePharmaceutics2022

Drug-Drug Interaction Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Ipatasertib in Combination with Darolutamide in Patients with Advanced Prostate Cancer.

Dhruvitkumar S Sutaria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.